D. E. Shaw & Co., Inc. Regeneron Pharmaceuticals, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $43.2 Million - $50.7 Million	42,200 Added 14066.67%	42,500 $44.7 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $264,960 - $321,357	300 New	300 $315,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $16.9 Million - $21.4 Million	-29,500 Reduced 78.67%	8,000 $5.51 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $5.48 Million - $7.39 Million	-10,000 Reduced 21.05%	37,500 $22.2 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $9.58 Million - $11.2 Million	-16,100 Reduced 25.31%	47,500 $33.2 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $18.3 Million - $22.5 Million	33,600 Added 112.0%	63,600 $40.2 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $11.8 Million - $14 Million	-20,500 Reduced 40.59%	30,000 $18.2 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $9.69 Million - $11.5 Million	20,500 Added 68.33%	50,500 $28.2 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $1.3 Million - $1.59 Million	-2,900 Reduced 8.81%	30,000 $14.2 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $3.64 Million - $4.62 Million	-7,600 Reduced 18.77%	32,900 $15.9 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $2.56 Million - $3.09 Million	-4,700 Reduced 10.4%	40,500 $22.7 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $3.45 Million - $4.51 Million	7,000 Added 18.32%	45,200 $28.2 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $6.62 Million - $9.74 Million	19,700 Added 106.49%	38,200 $18.7 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $1.15 Million - $1.58 Million	-4,200 Reduced 18.5%	18,500 $6.95 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $297,664 - $351,656	800 Added 3.65%	22,700 $9.32 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $1.98 Million - $2.38 Million	-5,900 Reduced 21.22%	21,900 $8.18 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $3.41 Million - $3.96 Million	9,700 Added 53.59%	27,800 $11.2 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $1.57 Million - $1.9 Million	-5,500 Reduced 23.31%	18,100 $6.24 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $34 Million - $42.4 Million	-107,600 Reduced 82.01%	23,600 $8.13 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $10.1 Million - $13.3 Million	28,300 Added 27.5%	131,200 $49.3 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $44.4 Million - $51.9 Million	102,900	102,900 $46 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account